KR20010020094A - 모메타손 푸로에이트의 제조방법 - Google Patents
모메타손 푸로에이트의 제조방법 Download PDFInfo
- Publication number
- KR20010020094A KR20010020094A KR1019990048285A KR19990048285A KR20010020094A KR 20010020094 A KR20010020094 A KR 20010020094A KR 1019990048285 A KR1019990048285 A KR 1019990048285A KR 19990048285 A KR19990048285 A KR 19990048285A KR 20010020094 A KR20010020094 A KR 20010020094A
- Authority
- KR
- South Korea
- Prior art keywords
- mometasone
- furoate
- mometasone furoate
- reaction
- furoyl chloride
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (8)
- 불활성 용매중에서 삼차아민의 존재하에 모메타손을 2-푸로일 클로라이드와 반응시키는 것을 특징으로 하는 모메타손 푸로에이트의 제조방법.
- 제 1항에 있어서, 상기 삼차 아민은 트리에틸아민인 것을 특징으로 하는 모메타손 푸로에이트의 제조방법.
- 제 1항에 있어서, 상기 용매는 2-푸로일 클로라이드의 어떤 활성형도 반응동안 용액내에서 유지될 수 있는 비극성의 물과 섞이지 않는 용매인 것을 특징으로 하는 모메타손 푸로에이트의 제조방법.
- 제 1항 또는 제 3항에 있어서, 상기 불활성 용매는 디클로로메탄인 것을 특징으로 하는 모메타손 푸로에이트의 제조방법.
- 제 1항 내지 제 4항 중 어느 한 항에 있어서, 모메타손의 몰당량당 2.5~4몰당량의 2-푸로일 클로라이드가 사용되는 것을 특징으로 하는 모메타손 푸로에이트의 제조방법.
- 제 1항 내지 제 5항 중 어느 한 항에 있어서, 모메타손의 몰당량당 3~6몰당량의 트리에틸아민이 사용되는 것을 특징으로 하는 모메타손 푸로에이트의 제조방법.
- 제 1항 내지 제 6항 중 어느 한 한항에 있어서, 반응은 0~25℃사이의 온도에서 수행되는 것을 특징으로 하는 모메타손 푸로에이트의 제조방법.
- 제 1항 내지 제 7항 중 어느 한 항에 있어서, 모메타손 푸로에이트의 3과 20위치에 생성된 엔올 푸로에이트들을 제거하기 위하여 반응 생성물을 수성 염산으로 처리하는 것을 더 포함하는 것을 특징으로 하는 모메타손 푸로에이트의 제조방법.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PT102.343. | 1999-08-02 | ||
PT102343A PT102343B (pt) | 1999-08-02 | 1999-08-02 | Processo para a preparacao de furoato mometasona |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20010020094A true KR20010020094A (ko) | 2001-03-15 |
KR100640066B1 KR100640066B1 (ko) | 2006-10-31 |
Family
ID=20085881
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019990048285A KR100640066B1 (ko) | 1999-08-02 | 1999-11-03 | 모메타손 푸로에이트의 제조방법 |
Country Status (22)
Country | Link |
---|---|
US (1) | US6177560B1 (ko) |
EP (1) | EP1074558B1 (ko) |
JP (1) | JP3746174B2 (ko) |
KR (1) | KR100640066B1 (ko) |
CN (1) | CN1149222C (ko) |
AT (1) | ATE229970T1 (ko) |
AU (1) | AU765592B2 (ko) |
CA (1) | CA2295455C (ko) |
DE (1) | DE69904585T2 (ko) |
DK (1) | DK1074558T3 (ko) |
ES (1) | ES2189354T3 (ko) |
HR (1) | HRP990341B1 (ko) |
HU (1) | HU227494B1 (ko) |
IL (1) | IL133752A (ko) |
NO (1) | NO321154B1 (ko) |
NZ (1) | NZ500555A (ko) |
PL (1) | PL191103B1 (ko) |
PT (1) | PT102343B (ko) |
RU (1) | RU2208616C2 (ko) |
SI (1) | SI1074558T1 (ko) |
UA (1) | UA60333C2 (ko) |
ZA (1) | ZA996758B (ko) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070099883A1 (en) * | 2005-10-07 | 2007-05-03 | Cheryl Lynn Calis | Anhydrous mometasone furoate formulation |
EP1790754A1 (de) * | 2005-11-24 | 2007-05-30 | Siemens Aktiengesellschaft | Schichtsystem mit Gadolinium-Mischkristall-Pyrochlorphase |
US8021742B2 (en) * | 2006-12-15 | 2011-09-20 | Siemens Energy, Inc. | Impact resistant thermal barrier coating system |
PL3111926T3 (pl) | 2009-05-29 | 2020-06-29 | Pearl Therapeutics, Inc. | Kompozycje, sposoby i układy do dostarczania dwóch lub większej liczby środków czynnych do układu oddechowego |
US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
PT105139B (pt) * | 2010-06-01 | 2013-01-29 | Hovione Farmaciencia S A | Método para a monofluorometilação de substratos orgânicos para preparação de compostos orgânicos biologicamente activos |
US20140275517A1 (en) | 2013-03-15 | 2014-09-18 | Pearl Therapeutics, Inc. | Methods and systems for conditioning of particulate crystalline materials |
MX2015016058A (es) | 2013-05-22 | 2016-12-20 | Pearl Therapeutics Inc | Composiciones, metodos y sistemas para el suministro por via respiratoria de tres o mas agentes activos. |
CN105481933B (zh) * | 2015-12-25 | 2017-09-19 | 山东京卫制药有限公司 | 一种合成糠酸莫米松的方法 |
CN105566437B (zh) * | 2015-12-30 | 2018-07-20 | 山东京卫制药有限公司 | 一种8dm衍生物及利用其合成糠酸莫米松的方法 |
CN107266518B (zh) * | 2016-04-08 | 2021-03-30 | 天津金耀集团有限公司 | 一种糠酸莫米松晶型及其制备方法 |
WO2023283441A1 (en) | 2021-07-09 | 2023-01-12 | Astrazeneca Pharmaceuticals Lp | Compositions, methods and systems for aerosol drug delivery |
WO2023119093A1 (en) | 2021-12-20 | 2023-06-29 | Astrazeneca Ab | Compositions, methods and systems for aerosol drug delivery |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE8790T1 (de) * | 1981-02-02 | 1984-08-15 | Schering Corporation | Aromatische heterocyclische steroidester, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten. |
PT923599E (pt) * | 1996-06-28 | 2002-06-28 | Schering Corp | Processo para a preparacao de 17-esteres de 9alfa,21-di-halopregnano-11beta,17alfadiol-20-onas |
US5886200A (en) * | 1996-07-01 | 1999-03-23 | Schering Corporation | Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones |
-
1999
- 1999-08-02 NZ NZ500555A patent/NZ500555A/xx not_active IP Right Cessation
- 1999-08-02 PT PT102343A patent/PT102343B/pt unknown
- 1999-10-21 HU HU9903747A patent/HU227494B1/hu unknown
- 1999-10-22 AU AU56024/99A patent/AU765592B2/en not_active Expired
- 1999-10-25 SI SI9930173T patent/SI1074558T1/xx unknown
- 1999-10-25 DK DK99308380T patent/DK1074558T3/da active
- 1999-10-25 AT AT99308380T patent/ATE229970T1/de active
- 1999-10-25 EP EP99308380A patent/EP1074558B1/en not_active Expired - Lifetime
- 1999-10-25 DE DE69904585T patent/DE69904585T2/de not_active Expired - Lifetime
- 1999-10-25 ES ES99308380T patent/ES2189354T3/es not_active Expired - Lifetime
- 1999-10-26 NO NO19995225A patent/NO321154B1/no not_active IP Right Cessation
- 1999-10-27 ZA ZA9906758A patent/ZA996758B/xx unknown
- 1999-11-03 KR KR1019990048285A patent/KR100640066B1/ko active IP Right Grant
- 1999-11-03 RU RU99123183/04A patent/RU2208616C2/ru active
- 1999-11-04 UA UA99116069A patent/UA60333C2/uk unknown
- 1999-11-05 HR HR990341A patent/HRP990341B1/xx not_active IP Right Cessation
- 1999-11-05 PL PL336452A patent/PL191103B1/pl unknown
- 1999-11-05 JP JP31523699A patent/JP3746174B2/ja not_active Expired - Lifetime
- 1999-11-26 CN CNB991243803A patent/CN1149222C/zh not_active Expired - Lifetime
- 1999-12-27 IL IL13375299A patent/IL133752A/en not_active IP Right Cessation
- 1999-12-29 US US09/476,004 patent/US6177560B1/en not_active Expired - Lifetime
-
2000
- 2000-01-14 CA CA002295455A patent/CA2295455C/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2230748C2 (ru) | Способ получения кларитромицина в виде кристаллов формы ii | |
KR100640066B1 (ko) | 모메타손 푸로에이트의 제조방법 | |
RU2599452C2 (ru) | КРИСТАЛЛИЧЕСКАЯ СОЛЬВАТНАЯ ФОРМА КОРТЕКСОЛОН-17альфа-ПРОПИОНАТА, СПОСОБ ЕЕ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ЕЕ ОСНОВЕ | |
EP0389369B1 (fr) | Nouveaux stéroides 3-céto comportant une chaîne en 17 aminosubstituée, leur procédé de préparation et les intermédiaires de ce procédé, leur application comme médicaments et les compositions les contenant | |
JP4354809B2 (ja) | 抗男性ホルモン薬剤としての17アルファ,21−ジヒドロキシプレグネンエステル | |
MXPA02010967A (es) | Proceso de oxidacion para preparar acido 6-alfa., 9.alfa.-difluoro-11.beta., 17.alfa.-dihidroxi-16.alfa.-metil-androst-1,4-dien-3-ona 17.beta.-carboxilico intermedio. | |
AU725606B2 (en) | Process for the preparation of 17-esters of 9alpha,21- dihalo-pregnane-11beta,17alpha-diol-20-ones | |
AU775831B2 (en) | Process for preparing 17alpha-acetoxy-11beta-(4-N,N-(dimethylamino)phenyl)-21- methoxy-19-norpregna-4,9-diene-3,20-dione, intermediates useful in the process, and processes for preparing such intermediates | |
CN115716862A (zh) | 新型长效芸苔素内酯、合成方法及其应用 | |
JP2000503666A (ja) | Mappia foetidaから単離したカンプトセシン―骨格化合物および新規な医薬ならびに治療薬のためのシントンとしてのその使用 | |
EP0338065B1 (fr) | Derives de la 19-nor progesterone, leur preparation et leur utilisation | |
HU180520B (en) | Process for producing 17-alpha-alkinyl derivatives of 17-beta-hydroxy-andorst-4-ene-3-one | |
EP0003090B1 (fr) | Nouveaux dérivés stéroides 17 alpha-aryle ou 17 alpha-hétéroaryle, leur procédé de préparation et leur application comme médicaments et les compositions pharmaceutiques les renfermant | |
RU2161623C2 (ru) | Способ изомеризации эквилина | |
CN115785188B (zh) | 一种布地奈德的制备方法 | |
MXPA00000670A (es) | Proceso para la preparacion de furoato de mometasona | |
KR100500498B1 (ko) | 에스트로겐혼합물의황산화방법 | |
CA2584052C (en) | Process for the esterification of a carbothioic acid | |
WO1992001706A1 (fr) | Nouveaux derives de la 6-methyl 19-nor progesterone, substitue en 3 et leur procede d'obtention | |
US3264285A (en) | Novel 19-nor-testosterone-17-hemiacetals and -hemiacetal esters | |
KR800000555B1 (ko) | 스테로이드의 레티온산 에스테르의 제조방법 | |
JP2004002339A (ja) | 7α−ヒドロキシデヒドロエピアンドロステロンとその一部の誘導体の精製方法と得られた溶媒和物 | |
CS248729B2 (cs) | Způsob výroby derivátů 6a-niethylkortikoidu | |
CH598285A5 (en) | Steroid 21-(4-acetamidomethylcyclohexane carboxylates) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121019 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20131001 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20141006 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20150918 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20160921 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20170919 Year of fee payment: 12 |